Skip navigation

Strategic Forecasting, Accounting Estimates, Analytics and Financial Reporting for Life Science Companies

November 12-14, 2019
  • Philadelphia, PA

The materiality and complexity of gross-to-net within the life sciences sector continues to swell; Proactive and strategic management of GTN is critical. CBI’s longstanding Gross-to-Net Summit is built for biotech, pharma and generic drug companies of all sizes and stages. Whether your organization is pre-commercial revenue or is managing multiple products and large revenue streams, the GTN models and processes shared at the conference are paramount to success and compliance. Attendees consistently walk away with best practices for a well-designed, multi-faceted approach to GTN management for enhanced visibility, profitability and control.

NEW FOR 2019!

Pre-Summit Breakout Sessions on November 12th:

Attendees choose from two tailored workshops and provided with pre- and
post-workshop take home materials for a GTN playbook.

I. Industry 101 Boot Camp

GTN Process Establishment and Best Practices

II. Senior Executive Master Class

Next-Level Strategies for GTN Optimization

Main Conference Hot Topics:

  • Medicare Part D – Program Changes and Implications to GTN
  • Forecasting for Coverage Gap
  • PBM Rebates and Changing Pricing Environment —
    Scenario Planning and GTN Impact Review
  • Advanced Data and Financial Analytics for Pricing and Payer Contracting
  • Updates on 340B
  • Roadmap to Product Launch
  • Company Organizational Benchmarking — Best Practices for
    Structuring and Process Design for Large, Mid-Size and Small Companies
  • Applications of Digital Finance and Robotics within GTN
  • Pipeline Accruals and Demand Forecasting
  • Value-Based and Outcomes-Based Agreements and GTN
  • Product Returns and GTN
  • Medicaid and GP Programs

AUDIENCE ACCLAIM FROM CBI’S FINANCIAL SERIES:

The CBI Gross-to-Net Conference offers a broad range of experiences and knowledge to help navigate this
complex and unclear critical business area.

Manager, Chargebacks, Fresenius Kabi

Very worthwhile conference and relevant to all!

Associate Director, Finance, Ferring Pharmaceuticals

Amazed and impressed by the level of knowledge-sharing across the conference attendees.

Senior Manager, Technical Accounting, Sunovion Pharmaceuticals

Excellent opportunity to network with peers and opportunity to meet software vendors and solution providers.

Chief Financial Officer, Kowa Pharmaceuticals